Clinical Trial Update: Efficacy and Safety of Qibei Jiedu Formula for Preventing and Managing Acute Radiation Dermatitis in Breast Cancer Patients [NA]

View source ↗

Summary

Clinical trial entry for Qibei Jiedu Formula to prevent and manage acute radiation dermatitis in breast cancer patients; status is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Radiation Dermatitis

Drugs mentioned

• Qibei Jiedu Formula

Snippet

Sponsor: LI FENG | Conditions: Acute Radiation Dermatitis, Traditional Chinese Medicine (TCM) | NA | Status: NOT_YET_RECRUITING